Mylan-lamotrigine(2021-03-29)

Lamotrigine Recall Summary Mylan is recalling lamotrigine, a medication distributed across Canada, due to product safety concerns. Lamotrigine is a drug used to treat seizures and certain mood disorders. This is a Class I recall, which indicates a serious safety issue.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2021-03-29
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/631c9c33-8f85-49de-ace6-492b20adc5a4